APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Typhoid Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Typhoid Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174044010326 December 2025189 pages

Choose your research edition.

Industry ResearchTyphoid Vaccine Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Typhoid Vaccine Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Typhoid Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Typhoid Vaccine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Typhoid Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Typhoid Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Typhoid Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Typhoid Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Typhoid Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Typhoid Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Typhoid Vaccine include Actiza Pharmaceutical, Bharat Biotec, Merit Pharmaceuticals, PaxVax, GlaxoSmithKline, Merck and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Typhoid Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Typhoid Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Typhoid Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Typhoid Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Typhoid Vaccine Segment by Company

Actiza Pharmaceutical

Bharat Biotec

Merit Pharmaceuticals

PaxVax

GlaxoSmithKline

Merck

Sanofi

Typhoid Vaccine Segment by Type

Oral Type Typhoid Vaccine

Injection Type Typhoid Vaccine

Typhoid Vaccine Segment by Application

Pharmaceutical & Biotechnology Companies

Hospital

Research & Academic Laboratories

Others

Typhoid Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Typhoid Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Typhoid Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Typhoid Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Typhoid Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Typhoid Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Typhoid Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Typhoid Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Typhoid Vaccine Industry Trends Table 2. Typhoid Vaccine Industry Drivers Table 3. Typhoid Vaccine Industry Opportunities and Challenges Table 4. Typhoid Vaccine Industry Restraints Table 5. Global Typhoid Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Typhoid Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Typhoid Vaccine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Typhoid Vaccine Sales Market Share by Manufacturers Table 9. Global Typhoid Vaccine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Typhoid Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Typhoid Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Typhoid Vaccine Manufacturers, Product Type & Application Table 13. Global Typhoid Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Typhoid Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Oral Type Typhoid Vaccine Table 17. Major Manufacturers of Injection Type Typhoid Vaccine Table 18. Global Typhoid Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Typhoid Vaccine Sales by Type (2021-2026) & (K Units) Table 20. Global Typhoid Vaccine Sales by Type (2027-2032) & (K Units) Table 21. Global Typhoid Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Typhoid Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Typhoid Vaccine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Typhoid Vaccine Revenue by Type (2021-2026) & (K Units) Table 25. Global Typhoid Vaccine Revenue by Type (2027-2032) & (K Units) Table 26. Global Typhoid Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Typhoid Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Pharmaceutical & Biotechnology Companies Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Research & Academic Laboratories Table 31. Major Manufacturers of Others Table 32. Global Typhoid Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Typhoid Vaccine Sales by Application (2021-2026) & (K Units) Table 34. Global Typhoid Vaccine Sales by Application (2027-2032) & (K Units) Table 35. Global Typhoid Vaccine Sales Market Share by Application (2021-2026) Table 36. Global Typhoid Vaccine Sales Market Share by Application (2027-2032) Table 37. Global Typhoid Vaccine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Typhoid Vaccine Revenue by Application (2021-2026) & (K Units) Table 39. Global Typhoid Vaccine Revenue by Application (2027-2032) & (K Units) Table 40. Global Typhoid Vaccine Revenue Market Share by Application (2021-2026) Table 41. Global Typhoid Vaccine Revenue Market Share by Application (2027-2032) Table 42. Global Typhoid Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Typhoid Vaccine Sales by Region (2021-2026) & (K Units) Table 44. Global Typhoid Vaccine Sales Market Share by Region (2021-2026) Table 45. Global Typhoid Vaccine Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Typhoid Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Typhoid Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Typhoid Vaccine Sales by Country (2021-2026) & (K Units) Table 49. North America Typhoid Vaccine Sales by Country (2027-2032) & (K Units) Table 50. Europe Typhoid Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Typhoid Vaccine Sales by Country (2021-2026) & (K Units) Table 52. Europe Typhoid Vaccine Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Typhoid Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Typhoid Vaccine Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Typhoid Vaccine Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Typhoid Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Typhoid Vaccine Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Typhoid Vaccine Sales by Country (2027-2032) & (K Units) Table 59. Global Typhoid Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Typhoid Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Typhoid Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Typhoid Vaccine Revenue Market Share by Region (2021-2026) Table 63. Global Typhoid Vaccine Revenue Market Share by Region (2027-2032) Table 64. Actiza Pharmaceutical Company Information Table 65. Actiza Pharmaceutical Business Overview Table 66. Actiza Pharmaceutical Typhoid Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Actiza Pharmaceutical Typhoid Vaccine Product Portfolio Table 68. Actiza Pharmaceutical Recent Development Table 69. Bharat Biotec Company Information Table 70. Bharat Biotec Business Overview Table 71. Bharat Biotec Typhoid Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Bharat Biotec Typhoid Vaccine Product Portfolio Table 73. Bharat Biotec Recent Development Table 74. Merit Pharmaceuticals Company Information Table 75. Merit Pharmaceuticals Business Overview Table 76. Merit Pharmaceuticals Typhoid Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Merit Pharmaceuticals Typhoid Vaccine Product Portfolio Table 78. Merit Pharmaceuticals Recent Development Table 79. PaxVax Company Information Table 80. PaxVax Business Overview Table 81. PaxVax Typhoid Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. PaxVax Typhoid Vaccine Product Portfolio Table 83. PaxVax Recent Development Table 84. GlaxoSmithKline Company Information Table 85. GlaxoSmithKline Business Overview Table 86. GlaxoSmithKline Typhoid Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. GlaxoSmithKline Typhoid Vaccine Product Portfolio Table 88. GlaxoSmithKline Recent Development Table 89. Merck Company Information Table 90. Merck Business Overview Table 91. Merck Typhoid Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Merck Typhoid Vaccine Product Portfolio Table 93. Merck Recent Development Table 94. Sanofi Company Information Table 95. Sanofi Business Overview Table 96. Sanofi Typhoid Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Sanofi Typhoid Vaccine Product Portfolio Table 98. Sanofi Recent Development Table 99. Key Raw Materials Table 100. Raw Materials Key Suppliers Table 101. Typhoid Vaccine Distributors List Table 102. Typhoid Vaccine Customers List Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Typhoid Vaccine Product Image Figure 2. Global Typhoid Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Typhoid Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Typhoid Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Typhoid Vaccine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Typhoid Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Oral Type Typhoid Vaccine Image Figure 9. Injection Type Typhoid Vaccine Image Figure 10. Global Typhoid Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Typhoid Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Typhoid Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Typhoid Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Typhoid Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Typhoid Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Pharmaceutical & Biotechnology Companies Image Figure 17. Hospital Image Figure 18. Research & Academic Laboratories Image Figure 19. Others Image Figure 20. Global Typhoid Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Typhoid Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Typhoid Vaccine Sales Market Share by Application (2021-2032) Figure 23. Global Typhoid Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Typhoid Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Typhoid Vaccine Revenue Market Share by Application (2021-2032) Figure 26. North America Typhoid Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Typhoid Vaccine Sales Market Share by Country (2021-2032) Figure 28. U.S. Typhoid Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Typhoid Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Typhoid Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Typhoid Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Typhoid Vaccine Sales Market Share by Country (2021-2032) Figure 33. Germany Typhoid Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Typhoid Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Typhoid Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Typhoid Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Typhoid Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Typhoid Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Typhoid Vaccine Sales Market Share by Country (2021-2032) Figure 40. China Typhoid Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Typhoid Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Typhoid Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Typhoid Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Typhoid Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Typhoid Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Typhoid Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Typhoid Vaccine Sales Market Share by Country (2021-2032) Figure 48. Brazil Typhoid Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Typhoid Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Typhoid Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Typhoid Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Typhoid Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Typhoid Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Typhoid Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Typhoid Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Typhoid Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Typhoid Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Typhoid Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. North America Typhoid Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Typhoid Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Europe Typhoid Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Typhoid Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Typhoid Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Typhoid Vaccine Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Typhoid Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Typhoid Vaccine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Typhoid Vaccine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Type Typhoid Vaccine
  • Injection Type Typhoid Vaccine
Applications
  • Pharmaceutical & Biotechnology Companies
  • Hospital
  • Research & Academic Laboratories
  • Others
Companies covered
  • Actiza Pharmaceutical
  • Bharat Biotec
  • Merit Pharmaceuticals
  • PaxVax
  • GlaxoSmithKline
  • Merck
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Typhoid Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Typhoid Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Typhoid Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Typhoid Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Typhoid Vaccine Market Dynamics
  1. 2.1 Typhoid Vaccine Industry Trends
  2. 2.2 Typhoid Vaccine Industry Drivers
  3. 2.3 Typhoid Vaccine Industry Opportunities and Challenges
  4. 2.4 Typhoid Vaccine Industry Restraints
3 Typhoid Vaccine Market by Manufacturers
  1. 3.1 Global Typhoid Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Typhoid Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Typhoid Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Typhoid Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Typhoid Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Typhoid Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Typhoid Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Typhoid Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Typhoid Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Typhoid Vaccine Tier 1, Tier 2, and Tier 3
4 Typhoid Vaccine Market by Type
  1. 4.1 Typhoid Vaccine Type Introduction
  2. 4.1.1 Oral Type Typhoid Vaccine
  3. 4.1.2 Injection Type Typhoid Vaccine
  4. 4.2 Global Typhoid Vaccine Sales by Type
  5. 4.2.1 Global Typhoid Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Typhoid Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Typhoid Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Typhoid Vaccine Revenue by Type
  9. 4.3.1 Global Typhoid Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Typhoid Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Typhoid Vaccine Revenue Market Share by Type (2021-2032)
5 Typhoid Vaccine Market by Application
  1. 5.1 Typhoid Vaccine Application Introduction
  2. 5.1.1 Pharmaceutical & Biotechnology Companies
  3. 5.1.2 Hospital
  4. 5.1.3 Research & Academic Laboratories
  5. 5.1.4 Others
  6. 5.2 Global Typhoid Vaccine Sales by Application
  7. 5.2.1 Global Typhoid Vaccine Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Typhoid Vaccine Sales by Application (2021-2032)
  9. 5.2.3 Global Typhoid Vaccine Sales Market Share by Application (2021-2032)
  10. 5.3 Global Typhoid Vaccine Revenue by Application
  11. 5.3.1 Global Typhoid Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Typhoid Vaccine Revenue by Application (2021-2032)
  13. 5.3.3 Global Typhoid Vaccine Revenue Market Share by Application (2021-2032)
6 Global Typhoid Vaccine Sales by Region
  1. 6.1 Global Typhoid Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Typhoid Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Typhoid Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Typhoid Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Typhoid Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Typhoid Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Typhoid Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Typhoid Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Typhoid Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Typhoid Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Typhoid Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Typhoid Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Typhoid Vaccine Revenue by Region
  1. 7.1 Global Typhoid Vaccine Revenue by Region
  2. 7.1.1 Global Typhoid Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Typhoid Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Typhoid Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Typhoid Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Typhoid Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Typhoid Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Typhoid Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Typhoid Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Typhoid Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Typhoid Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Typhoid Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Typhoid Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Actiza Pharmaceutical
  2. 8.1.1 Actiza Pharmaceutical Company Information
  3. 8.1.2 Actiza Pharmaceutical Business Overview
  4. 8.1.3 Actiza Pharmaceutical Typhoid Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Actiza Pharmaceutical Typhoid Vaccine Product Portfolio
  6. 8.1.5 Actiza Pharmaceutical Recent Developments
  7. 8.2 Bharat Biotec
  8. 8.2.1 Bharat Biotec Company Information
  9. 8.2.2 Bharat Biotec Business Overview
  10. 8.2.3 Bharat Biotec Typhoid Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bharat Biotec Typhoid Vaccine Product Portfolio
  12. 8.2.5 Bharat Biotec Recent Developments
  13. 8.3 Merit Pharmaceuticals
  14. 8.3.1 Merit Pharmaceuticals Company Information
  15. 8.3.2 Merit Pharmaceuticals Business Overview
  16. 8.3.3 Merit Pharmaceuticals Typhoid Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merit Pharmaceuticals Typhoid Vaccine Product Portfolio
  18. 8.3.5 Merit Pharmaceuticals Recent Developments
  19. 8.4 PaxVax
  20. 8.4.1 PaxVax Company Information
  21. 8.4.2 PaxVax Business Overview
  22. 8.4.3 PaxVax Typhoid Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 PaxVax Typhoid Vaccine Product Portfolio
  24. 8.4.5 PaxVax Recent Developments
  25. 8.5 GlaxoSmithKline
  26. 8.5.1 GlaxoSmithKline Company Information
  27. 8.5.2 GlaxoSmithKline Business Overview
  28. 8.5.3 GlaxoSmithKline Typhoid Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GlaxoSmithKline Typhoid Vaccine Product Portfolio
  30. 8.5.5 GlaxoSmithKline Recent Developments
  31. 8.6 Merck
  32. 8.6.1 Merck Company Information
  33. 8.6.2 Merck Business Overview
  34. 8.6.3 Merck Typhoid Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Merck Typhoid Vaccine Product Portfolio
  36. 8.6.5 Merck Recent Developments
  37. 8.7 Sanofi
  38. 8.7.1 Sanofi Company Information
  39. 8.7.2 Sanofi Business Overview
  40. 8.7.3 Sanofi Typhoid Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sanofi Typhoid Vaccine Product Portfolio
  42. 8.7.5 Sanofi Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Typhoid Vaccine Value Chain Analysis
  2. 9.1.1 Typhoid Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Typhoid Vaccine Production Mode & Process
  6. 9.2 Typhoid Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Typhoid Vaccine Distributors
  9. 9.2.3 Typhoid Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst